ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Peptide Lash Serum For Longer Fuller Eyelashes: Natural Formula Announced

Trybello introduces a peptide-based eyelash serum formulated with naturally derived ingredients designed to support lash strength, hydration, and visible fullness, reflecting increasing consumer interest in science-informed cosmetic care products.

-- Trybello has announced its Bello Eyelash Serum, a peptide-based formulation designed to support longer, fuller eyelashes through a combination of naturally derived ingredients and targeted hair-supporting compounds. The product reflects growing consumer interest in cosmetic solutions that focus on lash health and gradual improvement rather than short-term cosmetic enhancements.

More information is available at https://trybello.com/collections/shop-eyelashes

Many individuals experience thinning or weakened eyelashes due to aging, cosmetic treatments, or repeated use of extensions. In response, the beauty and personal care market has seen increased demand for topical products intended to support natural lash growth and improve overall lash condition. The Trybello formulation incorporates several ingredients commonly used in hair-care science to strengthen follicles and improve moisture balance.

The serum’s formulation includes Myristoyl Pentapeptide-17, a peptide associated with keratin production, along with additional ingredients such as hyaluronic acid, vitamin E, biotin, and panthenol. These compounds are frequently used in cosmetic formulations to help maintain hair structure, improve hydration, and support the appearance of stronger strands.

Recent clinical research examining Myristoyl Pentapeptide-17 has reported measurable improvements in eyelash length and density when used consistently. In a controlled study evaluating the ingredient at a 10 percent concentration, participants experienced a 23 percent increase in eyelash length and density after two weeks of application, with results rising to 71 percent after six weeks. These findings have contributed to broader interest in peptide-based cosmetic formulations designed to support visible lash enhancement over time.

Trybello states that their serum focuses on ingredient transparency and compatibility with sensitive skin around the eye area. The formulation is free from oils, hormones, silicones, parabens, perfumes, and PEG compounds, and is designated as vegan and cruelty-free. The product has undergone dermatological testing and is intended for daily use as part of a regular cosmetic care routine.

According to the company, consistent use may lead to visible changes in lash thickness and length over several weeks, although individual outcomes vary depending on factors such as hair growth cycles and previous cosmetic treatments.

For more details, visit https://trybello.com/

Contact Info:
Name: TryBello
Email: Send Email
Organization: Trybello LLC
Address: 40 SW 13th St Ste 902, Miami, Florida 33130, United States
Website: https://trybello.com/

Source: PressCable

Release ID: 89187604

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  238.38
+4.73 (2.02%)
AAPL  260.48
-0.01 (-0.00%)
AMD  245.04
+8.40 (3.55%)
BAC  52.54
-0.17 (-0.32%)
GOOG  315.72
-0.65 (-0.21%)
META  629.86
+1.47 (0.23%)
MSFT  370.87
-2.20 (-0.59%)
NVDA  188.63
+4.72 (2.57%)
ORCL  138.09
+0.23 (0.17%)
TSLA  348.95
+3.33 (0.96%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.